Efficacy, safety and tolerability of XM17 compared to Gonal-f in women undergoing assisted reproductive technologies: a multinational, multicentre, randomised, controlled, assessor-blind, parallel group phase III study including follow-up periods.
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2014
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors BioGeneriX
- 16 Aug 2014 Status changed from recruiting to completed as reported by EudraCT record.
- 24 May 2010 New trial record